Article Text

Download PDFPDF
798 The feasibility of sentinel lymph node biopsy in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia: a Turkish gynecologic oncology group study (TRSGO-SLN-011)
  1. Seda sahin Aker1,
  2. Ali Gokce2,
  3. Fatma Çevik Kaya1,
  4. Çagatayhan Öztürk2,
  5. Dogan Vatansever3,
  6. Ibrahim Yalçin4,
  7. Ozguc Takmaz5,
  8. GIZEM Çetinkaya2,
  9. Gülsah Dilci Yildirim1,
  10. Necati Berk Kaplan2,
  11. Sultan Çaliskan4,
  12. Salih Taskin2,
  13. Cagatay Taskiran3 and
  14. Mete Gungor5
  1. 1Kayseri City Education and Training Hospital, Kayseri, Türkiye
  2. 2Ankara University Faculty of Medicine, Ankara, Turkey
  3. 3Koc University School of Medicine, Istanbul, Turkey
  4. 4Ondokuz Mayis University, Samsun, Turkey
  5. 5Acibadem University School of Medicine, Istanbul, Turkey


Introduction/Background Endometrial intraepithelial neoplasia (EIN) is a precancerous lesion with potential progression to endometrial cancer (EC). The decision to perform sentinel lymph node (SLN) assessment in patients with a preoperative diagnosis of EIN is complex.This study aims to evaluate the utility of SLN assessment, the risk of lymph node involvement and the prevalence of underlying cancer.

Methodology The study was conducted at five Turkish gynecologic oncology institutions enrolling 114 patients with a preoperative diagnosis of EIN. All patients underwent hysterectomy, bilateral salpingectomy, optional oophorectomy, and SLN assessment. The rate of EC and the sensitivity of SLN were calculated.

Results 114 patients included in the study. 48 were diagnosed with EC (42.1%), 42 with EIN (38.6%), and 21 with simple hyperplasia (19.3%).7 of 48 EC patients had high-risk factors including deep myometrial invasion, high-grade disease and lymphatic metastasis. Of the 18 patients with a preoperative diagnosis of EIN with high suspicion for carcinoma, 11 (61.1%) were diagnosed with EC at final pathology. Unilateral SLN detection was 100% of all patients and bilateral SLN node detection rate was 82.4%. Malign SLN detected in 2 patients (4.16%) in EC group. Five patients received adjuvant EBRT, and two underwent chemotherapy combined with brachytherapy and EBRT. 15 patients had an elevated CA125 level ( >35 U/ml) and 9 of them(60%) had a diagnosis of EC .

Conclusion Concomitant EC rate is 42.1% in patients with EIN and the risk increases to 61.1% in patients diagnosed with EIN with high suspicion for carcinoma. 14.5% of the EC (n=7) cases had at least 1 high risk factor for lymphatic metastasis or had lymph node involvement. SLN mapping might be a feasible approach particularly in patients with suspicion for carcinoma on preoperative pathology evaluation and/or elevated CA125 levels to avoid restaging surgery for lymph node status.

Disclosures No disclosure.

Abstract 798 Table 1

Demographic variables of patients

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.